The global metabolomics market should reach $22.7 billion by 2026 from $12.7 billion in 2021 at a compound annual growth rate (CAGR) of 12.3% for the forecast period of 2021 to 2026.
The separation techniques segment of the global metabolomics market is expected to grow from $5.1 billion in 2021 to $8.7 billion in 2026 at a CAGR of 11.3% for the forecast period of 2021 to 2026.
The detection techniques segment of the global metabolomics market is expected to grow from $4.0 billion in 2021 to $7.1 billion in 2026 at a CAGR of 12.4% for the forecast period of 2021 to 2026.
Report Scope
This report examines the current and forecasted market potential for metabolomics. It offers a detailed analysis of the market background, technological advancement, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for metabolomics based on product, indication and application type.
By product, the metabolomics market is segmented into separation techniques, detection techniques, assays, and bioinformatics. By indication type, the metabolomics market is segmented into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others. The other segment covers respiratory diseases, infectious diseases, etc. By application, the metabolomics market is segmented into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, and others.
By geography, the metabolomics market has been segmented into Europe, North America, Asia-Pacific (APAC), Latin America, and the Middle East & Africa (MEA). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India, and China are found in the regional segments. For market estimates, data is provided for 2020 as the base year, for 2021 and forecast through year-end 2026. Estimated values used are based on metabolomics companies’ total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.
The Report Includes
- 59 tables
- An overview and industry analysis of the global markets for metabolomics technologies
- Analyses of global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Assessment of the key marketed products and recent product launches, the regulatory landscape across different demographics covering North America, Europe, Asia-Pacific, Latin America and the Middle East
- Coverage of history and pathways of metabolomics, information on metabolomes and their sources like large bowel microflora, urine metabolome, food metabolome and comparison between lipidomes and lipidomics
- Highlights of the market potential for metabolomics market by product, indication, application, and region; assessment of investment in metabolomics research and spending in pharmaceutical and biotech R&D
- Information on targeted and untargeted approaches for metabolomic technology and complexity associated with data examination and processing
- Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
- Detailed profiles of the leading companies in the metabolomics market, including Agilent Technologies, Bio-Rad, Danaher Corp., Merck KGaA, Promega Corp. and Thermo Fisher Scientific
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- What's New in This Report
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Custom Research
- Related Reports
Chapter 2 Summary and Highlights
- Highlights of the Market for Metabolomics
Chapter 3 Overview of Metabolomics
- Introduction
- Metabolites
- Metabolomics
- Metabolomic History
- Metabolic Pathways
- Metabolomes
- Large Bowel Microflora
- Urine Metabolome
- Food Metabolome
- Lipidomes and Lipidomics
- Fluxomics
- Metabolomic Process Steps
- Sample Preparation
- Extraction
- Derivatization
- Separation and Detection
- Data Analysis
- Metabolomic Technology
- Targeted and Untargeted Approaches
- Applications
Chapter 4 Metabolomics: Pipeline Analysis
- Overview
Chapter 5 Metabolomics: Market Dynamics
- Metabolomics Market Drivers
- Increasing Investment in Metabolomic Research
- Increase in Demand for Personalized Medicine
- Increasing Pharmaceutical and Biotech R&D Spending
- Technological Advancements
- Increasing Use of Metabolomics in Toxicology Testing
- Market Restraints
- Complexity Associated with Data Examination and Processing
- High Cost of Tools and Instruments
- Dearth of Skilled Researchers
- Industry Insights
- Market Trends
Chapter 6 Impact of COVID-19 Pandemic
- Introduction
- Outbreak
- Impact of COVID-19 on Metabolomics
Chapter 7 Global Metabolomics Market Breakdown by Product
- Introduction
- Separation Techniques
- Chromatography
- Detection Techniques
- Mass Spectrometry
- Spectroscopy
- Assays
- Bioinformatics and Systems Biology Tools
Chapter 8 Global Metabolomics Market Breakdown by Indication
- Introduction
- Market Breakdown
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Inborn Errors of Metabolism
Chapter 9 Global Metabolomics Market Breakdown by Application
- Introduction
- Biomarker Discovery
- Drug Discovery
- Toxicology Testing
- Nutrigenomics
- Functional Genomics
Chapter 10 Global Metabolomics Market Breakdown by Region
- Introduction
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- Latin America
- Middle East and Africa (MEA)
Chapter 11 Competitive Landscape
- Global Company Share Analysis
- Mergers and Acquisitions
- Agreements, Collaborations, Product Launches, and Partnerships
Chapter 12 Company Profiles
- Agilent Technologies Inc.
- Biocrates Life Sciences Ag
- Bio-Rad Laboratories Inc.
- Biovision Inc.
- Bruker Corp.
- Chenomx
- Danaher Corp.
- Drumetix Laboratories Llc
- Gerstel Gmbh & Co. Kg
- Human Metabolome Technologies America Inc.
- Leco Corp.
- Merck Kgaa
- Metabolomic Diagnostics
- Metabolomic Technologies Inc.
- Metabolon Inc.
- One Way Liver Genomics S.L.
- Perkinelmer Inc.
- Promega Corp.
- Qiagen N.V.
- Shimadzu Corp.
- Stemina Biomarker Discovery Inc.
- Thermo Fisher Scientific Inc.
List of Tables
Summary Table: Global Market for Metabolomics, by Product Type, Through 2026
Table 1: Publications Referencing Metabolomics, 2008-2018
Table 2: Major Approaches in Metabolomics and their Advantages and Disadvantages
Table 3: Some Pipeline Clinical Trial Studies for Metabolomics
Table 4: Recent Funding Programs in Metabolomics
Table 5: Common Hyphenated Platforms in Metabolomic Research
Table 6: Global Market for Metabolomics, by Product Type, Through 2026
Table 7: Global Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 8: Global Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
Table 9: Global Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 10: Mass Spectroscopy Suppliers for the Life Sciences
Table 11: Global Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
Table 12: High-Content Screening Suppliers and Key Attributes
Table 13: Assays Commonly Used with Metabolomic Assays
Table 14: Metabolomic Public Resources
Table 15: Global Market for Metabolomics, by Indication, Through 2026
Table 16: Representation of Pathways, Functions of Metabolites and Possible Biomarkers in Animal Model and Human-Based Studies of Various Neuropsychiatric Disorders
Table 17: Global Market for Metabolomics, by Application, Through 2026
Table 18: Global Market for Metabolomics, by Region, Through 2026
Table 19: North American Market for Metabolomics, by Product Type, Through 2026
Table 20: North American Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 21: North American Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
Table 22: North American Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 23: North American Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
Table 24: North American Market for Metabolomic Assays, by Product Type, Through 2026
Table 25: North American Market for Metabolomics, by Indication, Through 2026
Table 26: North American Market for Metabolomics, by Application, Through 2026
Table 27: European Market for Metabolomics, by Product Type, Through 2026
Table 28: European Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 29: European Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
Table 30: European Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 31: European Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
Table 32: European Market for Metabolomic Assays, by Product Type, Through 2026
Table 33: European Market for Metabolomics, by Indication, Through 2026
Table 34: European Market for Metabolomics, by Application, Through 2026
Table 35: Asia-Pacific Market for Metabolomics, by Product Type, Through 2026
Table 36: Asia-Pacific Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 37: Asia-Pacific Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
Table 38: Asia-Pacific Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 39: Asia-Pacific Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
Table 40: Asia-Pacific Market for Metabolomic Assays, by Product Type, Through 2026
Table 41: Asia-Pacific Market for Metabolomics, by Indication, Through 2026
Table 42: Asia-Pacific Market for Metabolomics, by Application, Through 2026
Table 43: Latin American Market for Metabolomics, by Product Type, Through 2026
Table 44: Latin American Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 45: Latin American Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
Table 46: Latin American Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 47: Latin American Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
Table 48: Latin American Market for Metabolomic Assays, by Product Type, Through 2026
Table 49: Latin American Market for Metabolomics, by Indication, Through 2026
Table 50: Latin American Market for Metabolomics, by Application, Through 2026
Table 51: Middle Eastern and African Market for Metabolomics, by Product Type, Through 2026
Table 52: Middle Eastern and African Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 53: Middle Eastern and African Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
Table 54: Middle Eastern and African Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 55: Middle Eastern and African Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
Table 56: Middle Eastern and African Market for Metabolomic Assays, by Product Type, Through 2026
Table 57: Middle Eastern and African Market for Metabolomics, by Indication, Through 2026
Table 58: Middle Eastern and African Market for Metabolomics, by Application, Through 2026
List of Figures
Summary Figure: Global Market for Metabolomics, by Product Type, 2020-2026
Figure 1: Publications Referencing Metabolomics, 2008-2018
Figure 2: Cellular Respiration Stages
Figure 3: Factors Impacting Enzyme Activity
Figure 4: Typical Analytical Metabolomic Process Steps
Figure 5: Schematic Representation of a Metabolomic Workflow
Figure 6: Bioinformatic Processes for Metabolomics
Figure 7: Global Market for Metabolomics, by Region, 2020
Figure 8: Global Metabolomics Market Share Analysis, by Company, 2020
Figure 9: Agilent: Annual Revenue, 2018-2020
Figure 10: Agilent: Revenue Share, by Geography, 2020
Figure 11: Agilent: Revenue Share, by Segment, 2020
Figure 12: Bio-Rad: Annual Revenue, 2018-202
Figure 13: Bio-Rad: Revenue Share, by Segment, 2020
Figure 14: Bruker: Annual Revenue, 2018-2020
Figure 15: Bruker: Revenue Share, by Region, 2020
Figure 16: Danaher Corp.: Annual Revenue, 2018-2020
Figure 17: Danaher Corp.: Revenue Share, by Geography, 2020
Figure 18: Danaher Corp.: Revenue Share, by Segment, 2020
Figure 19: Merck KGaA: Annual Revenue, 2019 and 2020
Figure 20: Merck KGaA: Revenue Share, by Region, 2020
Figure 21: Merck KGaA: Revenue Share, by Segment, 2020
Figure 22: Thermo Fisher Scientific: Annual Revenue, 2019 and 2020
Figure 23: Thermo Fisher Scientific: Revenue Share, by Segment, 2020
Executive Summary
A shortage of qualified technicians, the high cost of instruments and tools, and the complexity affiliated with metabolomic data examination and processing pose threats to market growth.
Due to the increasing need for accurate diagnosis of diseases, rising demand for personalized medicine, increasing pharmaceutical and biotech research and development, and the availability of government and private funding, metabolomics is carving a greater presence in medicine and healthcare. As well, since it is non-invasive in nature and closely linked to the phenotype, metabolomics is an ideal tool for use in agricultural industries, pharmaceuticals and preventive healthcare. A rise in the number of clinical trials, awareness about nutritional products, toxicological testing data, and rapid growth of metabolomics data analysis software and solutions are expected to propel the growth of this market.
High growth in this segment is mainly attributed to the increasing usage of different bioinformatics platforms in several metabolomic applications such as drug discovery and development and the benefit of smooth technological workflow with the reliable, precise and transparent data processing benefits gained from it.
In addition, the easy availability of technologically advanced products and significant investments in metabolomic-based research in personalized medicine, drug discovery studies and cancer therapeutics will also drive the North American market during the forecast period. Asia-Pacific's high growth rate is attributed to the high prevalence of cancer, unmet healthcare needs, high investments in metabolomics-based research, and growing R&D funding for cancer drug discovery and personalized medicine opportunities.
Metabolomics studies focus on metabolite perturbations induced by infection and diseases. As direct signatures of disease onset and infection, metabolites can help researchers quickly determine pathogenesis, potential therapeutic targets, and cell or tissue damage. They can also be used as biomarkers to monitor disease progression. At present, metabolomics, including amino acid metabolism, glucose metabolism, lipid metabolism, purine and pyrimidine metabolism, and so on, have been widely applied in the COVID-19 pandemic.
Companies Mentioned
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Biocrates Life Sciences Ag
- Biovision Inc.
- Bruker Corp.
- Chenomx
- Danaher Corp.
- Drumetix Laboratories Llc
- Gerstel Gmbh & Co. Kg
- Human Metabolome Technologies America Inc.
- Leco Corp.
- Merck Kgaa
- Metabolomic Diagnostics
- Metabolomic Technologies Inc.
- Metabolon Inc.
- One Way Liver Genomics S.L.
- Perkinelmer Inc.
- Promega Corp.
- Qiagen N.V.
- Shimadzu Corp.
- Stemina Biomarker Discovery Inc.
- Thermo Fisher Scientific Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 157 |
| Published | November 2021 |
| Forecast Period | 2021 - 2026 |
| Estimated Market Value ( USD | $ 12.7 Billion |
| Forecasted Market Value ( USD | $ 22.7 Billion |
| Compound Annual Growth Rate | 12.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
